Androgenetic alopecia in COVID-19: Compared to what?

Affiliations

Comment

Benjamin A Nanes. J Am Acad Dermatol. 2020 Dec.

. 2020 Dec;83(6):e451.

doi: 10.1016/j.jaad.2020.06.1031. Epub 2020 Jul 29.

¹ Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: benjamin.nanes@utsouthwestern.edu.

No abstract available

Comment in

Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign.
Wambier CG, Vaño-Galván S, McCoy J, Pai S, Dhurat R, Goren A. Wambier CG, et al. J Am Acad Dermatol. 2020 Dec;83(6):e453-e454. doi: 10.1016/j.jaad.2020.07.099. Epub 2020 Jul 29. J Am Acad Dermatol. 2020. PMID: 32735970 Free PMC article.

Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign".
Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Fonda-Pascual P, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A. Wambier CG, et al. J Am Acad Dermatol. 2020 Aug;83(2):680-682. doi: 10.1016/j.jaad.2020.05.079. Epub 2020 May 22. J Am Acad Dermatol. 2020. PMID: 32446821 Free PMC article.

1. Wambier C.G., Vano-Galvan S., McCoy J. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: the “Gabrin sign.”. J Am Acad Dermatol. 2020;83(2):680–682. - PMC - PubMed
1. Severi G., Sinclair R., Hopper J.L. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol. 2003;149:1207–1213. - PubMed
1. Hamilton J.B. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci. 1951;53:708–728. - PubMed
1. Ramos P.M., Miot H.A. Female pattern hair loss: a clinical and pathophysiological review. An Bras Dermatol. 2015;90:529–543. - PMC - PubMed
1. Birch M.P., Messenger J.F., Messenger A.G. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol. 2001;144:297–304. - PubMed